Trial Condition(s):

Contraception

A study to evaluate inhibition of ovulation of two oral estrogen/progestogen regimens in healthy, young females over a period of 3 treatment cycles

Bayer Identifier:

91697

ClinicalTrials.gov Identifier:

NCT00631124

EudraCT Number:

2007-004544-73

Study Completed

Trial Purpose

Investigation of a new pill containing an estrogen and a progestin in order to monitor the inhibition of the ovulation in young healthy females over 3 treatment cycles

Inclusion Criteria
- Healthy female volunteers, 
- Age 18 - 35 years
Exclusion Criteria
- Contraindications for use of a combined (estrogen/progestogen) contraceptive (e.g. history of venous/arterial thromboembolic disease) 
- Regular intake of medication 
- Clinically relevant findings (ECG, blood pressure, physical, gynecological examination, laboratory examination) 
- Anovulatory pre-treatment cycle

Trial Summary

Enrollment Goal
103
Trial Dates
black-arrow
Phase
2
Could I receive a placebo?
No
Products
E2/DRSP (BAY86-4891)
Accepts Healthy Volunteers
Yes

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Bayer Pharma AG

Berlin, Germany, 13353

Status
Completed
 
Locations

Dinox GmbH Berlin

Berlin, Germany, 10115

Status
Completed
 

Trial Design